With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.578743-87-0,[1,3-Bis(2,6-diisopropylphenyl)imidazol-2-ylidene]copper chloride,as a common compound, the synthetic route is as follows.
In a glove box, IPrCuCl (224 mg, 0.46 mmol) and potassium tris(1-pyrazolyl)borohydride (127 mg, 0.50 mmol) in THF in a 40 mixture was stirred at room temperature for 3 hours dongan. Filtered through a plug of Celite and the reaction mixture after the evaporation of the solvent under reduced pressure to give product as a white powder IPrCuTp, 578743-87-0
As the paragraph descriping shows that 578743-87-0 is playing an increasingly important role.
Reference£º
Patent; University Of Southern California; Thompson, Mark E; Hamz, Rasya; Durovitch, Peter I; (50 pag.)KR2015/26932; (2015); A;,
Copper catalysis in organic synthesis – NCBI
Special Issue “Fundamentals and Applications of Copper-Based Catalysts”